GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 113 filers reported holding GW PHARMACEUTICALS PLC in Q3 2015. The put-call ratio across all filers is 2.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $348,000 | -26.4% | 3,471 | -11.3% | 0.01% | -23.1% |
| Q1 2017 | $473,000 | -81.3% | 3,911 | -79.5% | 0.01% | -78.3% |
| Q3 2016 | $2,528,000 | +493.4% | 19,047 | +309.0% | 0.06% | +566.7% |
| Q2 2016 | $426,000 | -87.2% | 4,657 | -89.9% | 0.01% | -90.4% |
| Q1 2016 | $3,321,000 | +227.2% | 46,024 | +456.8% | 0.09% | +422.2% |
| Q2 2015 | $1,015,000 | +316.0% | 8,266 | +174.1% | 0.02% | +260.0% |
| Q3 2014 | $244,000 | -83.1% | 3,016 | -77.6% | 0.01% | -77.3% |
| Q2 2014 | $1,441,000 | – | 13,441 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|